Background. Damage of microvascular endothelial cells is a salient feature of acute vascular rejection and chronic allograft nephropathy, yet specific blood markers of ongoing endothelial injury are currently unavailable. Circulating endothelial cells have recently been established as a novel marker of endothelial damage in a variety of vascular disorders.
donor origin and circulating immune cells of the recipient. During reperfusion, immunocompetent cells of the recipient first encounter donor epitopes, such as histocompatibility antigens, on donor endothelial cells. During vascular rejection, donor endothelial cells become the predominant focus of the immune attack. Endothelial damage is also an important feature of chronic allograft nephropathy, the single most common cause of long-term graft loss (1) . In particular, complement C4d deposition in peritubular capillaries has been demonstrated in a subgroup of patients, suggesting ongoing antibody-mediated injury (2) . Finally, endothelial cells are targets of drug toxicity, particularly by calcineurin inhibitors.
Nevertheless, few if any laboratory markers are currently available to indicate ongoing vascular injury. Biopsy samples, in contrast, may fail to reflect the true extent of endothelial damage because of sampling error. Markers of endothelial injury might thus be useful for detecting vascular rejection, studying the long-term course of vascular changes in chronic allograft nephropathy, or evaluating endothelial side effects of immunosuppressive drugs.
Circulating endothelial cells have recently been evaluated as a marker of endothelial injury in sickle cell disease (3), and more elegant techniques for their isolation have become available. In particular, we recently established that elevated numbers of circulating endothelial cells correlate with disease activity in antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (4) . Cell numbers proved to be a specific and sensitive marker for endothelial damage in this disorder. Given the need for such a marker in renal transplant recipients, we studied the use of circulating endothelial cells in these patients.
METHODS

Patients
We studied 129 renal transplant recipients (79 men and 50 women; mean age, 47 years) who underwent percutaneous graft biopsy 1 to 245 months (mean, 37 months) after renal transplantation. Biopsy was prompted by an increase in serum creatinine or proteinuria (nϭ81) or because of participation in a protocol biopsy scheme (nϭ48). At the time of biopsy, 64 patients received steroids and calcineurin inhibitors and 65 patients received triple maintenance immunosuppressive therapy (steroids, calcineurin inhibitor, and mycophenolate mofetil or azathioprine). 
Isolation of Circulating Endothelial Cells
Circulating endothelial cells were isolated from peripheral blood as described elsewhere (4) . Briefly, paramagnetic M-450 Dynabeads (Dynal, Hamburg, Germany) were coated with anti-CD146 antibody (Biocytex, Marseilles, France) (4) . CD146 is present exclusively on endothelial cells (5) and is believed to be a signaling molecule involved in the dynamics of actin cytoskeleton rearrangement (6) . Before graft biopsy, 15 mL of peripheral blood was obtained with a 21-gauge butterfly needle and the first 7.5 mL was discarded to avoid detection of endothelial cells dislodged by the venipuncture itself (4). Blood was diluted with buffer and FcR blocking agent (Miltenyi, Gladbach, Germany) and incubated with anti-CD146 -coated beads. Cells bound to anti-CD146 -coupled beads were separated from blood in a magnet, washed, mixed with acridine, and counted in a Nageotte chamber. The lower limit of detection was 4 cells/mL. To ensure that all isolated cells were indeed endothelial cells, Ulex europaeus lectin 1 (UEA-1) (Linaris, Wertheim, Germany) staining with counting was performed in parallel to acridine staining and counting. Cell numbers are given as meanϮSD and median. Cell numbers were compared with Kruskal-Wallis and Mann-Whitney U testing. Spearman rank correlation was used to calculate correlation.
RESULTS
Endothelial cells were larger than other blood cells, had a well-delineated round or oval cell shape, and carried more than five beads and stained UEA-1 positive (Fig. 1) . Smaller endothelial particles, as were seen in a previous study in ANCA-associated small-vessel vasculitis, were only occasionally observed in patients with vascular rejection but not in any other subgroup. Eventually, acridine-stained circulating endothelial cells could be identified on the basis of their morphology alone without concomitant immunocytochemistry.
Healthy controls had low numbers of circulating endothelial cells (7Ϯ5 cells/mL; median, 6 cells/mL). Renal transplant recipients with vascular rejection (nϭ7) had the highest numbers of circulating endothelial cells (72Ϯ39 cells/mL; median, 72 cells/mL). In particular, patients with vascular rejection had significantly higher cell numbers than healthy controls (PϽ0.001), patients without rejection (24Ϯ19 cells/ mL; median, 16 cells/mL; nϭ93; PϽ0.001), tubulointerstitial rejection (30Ϯ23 cells/mL; median, 24 cells/mL; nϭ15; PϽ0.02), and borderline rejection (32Ϯ24 cells/mL; median, 26 cells/mL; nϭ14; PϽ0.03) (Fig. 2 ). Among patients with vascular rejection, patients with severe intimal arteritis (Banff IIB) had higher numbers of circulating endothelial cells than those with mild intimal arteritis (Banff IIA) (Fig.  3) , although no formal statistical analyses were carried out. Cell numbers decreased during steroid treatment in one patient with vascular rejection (Fig. 4) . In this patient, the serum creatinine was 374 M at the time of the first endothelial cell measurement. There was transitory improvement of renal function after steroid treatment, but a further decline in renal function ensued and hemodialysis had to be instituted. All other patients (nϭ122) had higher cell numbers than healthy controls (PϽ0.001) regardless of the biopsy findings (Fig. 2) . We found a significant (PϽ0.01) but moderately strong (rϭ0.274) correlation of cell numbers with cyclosporine A trough levels. By contrast, there was no correlation with tacrolimus trough levels, sex, age, serum creatinine, or triple versus double immunosuppressive therapy. Patients with no human leukocyte antigen (HLA) mismatches at the A or B locus had lower numbers of circulating endothelial cells than patients with one or two HLA mismatches, although significance was only achieved for the B TRANSPLANTATION locus (PϽ0.03). There was a moderately strong (rϭϪ0.280) but significant (PϽ0.002) negative correlation of cell numbers with time since transplantation in all patients after patients with vascular rejection had been excluded (nϭ122).
DISCUSSION
Damage to endothelial cells is the hallmark of acute vascular rejection, which is an important predictor of graft loss (7) . Nevertheless, endothelial damage and cell death do not necessarily lead to scarring and loss of vascular function. Instead, repopulation of endothelial leaks by recipient stem cells has recently been documented in renal transplant recipients who have previously sustained acute vascular rejection (8) . A continuing interplay between vascular damage and repair is therefore postulated. This concept mandates that damaged endothelial cells undergo detachment from the basement membrane at some point of the disease process. Putative mechanisms of detachment and factors that protect against it have been reviewed elsewhere (9) . For the first time, we now demonstrate the occurrence of these detached endothelial cells in peripheral blood in patients with acute rejection. Further studies of the cell phenotype would be worthwhile for elucidating the mechanism of detachment from the basement membrane.
So far, studying endothelial injury in renal transplant recipients has been difficult and cumbersome, and novel markers of ongoing endothelial damage are needed. In particular, biopsy findings pertain only to graft endothelium and may underestimate vascular damage resulting from sampling error, yet blood markers of endothelial damage are not readily available. Anecdotal evidence suggests that factor VIII-related antigen may be useful (10) . The use of circulating endothelial cells, however, has not been evaluated before, although others have used this technique to identify endothelial cells infected with cytomegalovirus (11) . We have previously established the peripheral blood endothelial cell count as a marker of disease activity in ANCA-associated small-vessel vasculitis (4). We propose that circulating endothelial cells may be equally useful in renal transplant recipients.
Surprisingly, renal transplant recipients without any evidence of rejection also had elevated numbers of circulating endothelial cells, and causes other than vascular rejection must be sought. Recent research has elucidated endothelial damage in peritubular capillaries as a feature of chronic allograft nephropathy. Various factors, both immunologic and nonimmune, may be involved. In particular, complement C4 deposition in peritubular capillaries has been implicated in chronic antibody-mediated damage to peritubular endothelial cells (2) . Recently, this event has been documented to be an independent predictor of graft loss (12) . Peritubular capillaries have also been implicated in acute rejection (13) . Conceivably, the elevated cell numbers in our patients might reflect damage in peritubular capillaries. Unfortunately, simple markers of peritubular endothelium are not available at present.
However, endothelial damage and detachment may also occur beyond the boundaries of the graft and affect recipient endothelium. Death with a functioning graft is common, and cardiovascular events are responsible in approximately 40% of cases (14, 15) . It has been emphasized that some risk factors in renal transplant recipients stem from the time before and during dialysis, whereas others are only acquired with transplantation. In particular, immunosuppressive treatment has been implicated (16) . In this regard, toxicity of calcineurin inhibitors has been of greatest concern (17). These agents are capable of causing thrombotic microangiopathy, an endothelial disorder of unknown pathogenesis. In vivo, cyclosporine A has been shown to impair nitric oxide synthesis (18) , induce production of superoxide (19) , and enhance vascular permeability (20) . Moreover, induction of endothelial apoptosis (21) , release of von Willebrand factor (22) , and production of endothelin (23) have been reported in response to cyclosporine A. In line with these findings, we found a correlation of cell numbers with serum cyclosporine A trough levels, although there was no correlation with age, sex, or the number of immunosuppressive drugs. Moreover, we found a moderately strong but significant correlation of cell numbers with time since transplantation. This finding may further augment our hypothesis in that cyclosporine A levels are higher during the first months after transplantation, although other factors may also be at play. Patients with no HLA mismatches seemed to have lower cell numbers. Taken together, our findings point to both immune-mediated events and calcineurin inhibitors as the most likely explanation for elevated numbers of circulating endothelial cells in renal transplant recipients. The latter issue needs to be addressed in further studies, and we are currently investigating the number of circulating endothelial cells in renal transplant recipients who do not receive calcineurin inhibitors. 
